Please assess the completion status of the following clinical trial:

Trial Title: Feasibility of Adherence to Light Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* \[1\] Outpatients 19 to 65 years of age;~* \[2\] Diagnostic and Statistical Manual (DSM)-5 criteria for major depressive disorder (MDD) past or recurrent episode as determined by the Mini International Neuropsychiatric Interview;~* \[3\] taking an antidepressant for no more than six months;~* \[4\] participant desire to discontinue antidepressant treatment because of adverse effects or other reasons;~* \[5\] total score ≤10 on the clinician-rated Montgomery-Asberg Depression Rating Scale \[MADRS\];~* \[6\] Willing and able to complete self-report and online assessments including sufficient fluency in English.~Exclusion Criteria:~* \[1\] Any psychiatric diagnosis other than MDD that is considered the primary diagnosis, including Bipolar I or Bipolar-II (lifetime);~* \[2\] MDD with psychotic features (lifetime);~* \[3\] significant personality disorder diagnosis \[e.g., borderline, antisocial\];~* \[4\] High suicidal risk, defined by clinician judgment;~* \[5\] History of drug or alcohol abuse, with a severity of at least moderate or severe within 6 months before screening;~* \[6\] Significant neurological disorders, head trauma, or other unstable medical conditions;~* \[7\] regular use of psychotropic medication other than an antidepressant or benzodiazepines (e.g., antipsychotics, mood stabilizers);~* \[8\] history of severe withdrawal effects with antidepressant discontinuation;~* \[9\] retinal disease or other eye condition preventing use of bright light therapy;~* \[10\] use of photosensitizing medication within 1 week of baseline visit.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Light therapy (Type: OTHER): Daily exposure on weekdays to a standard light device (e.g., fluorescent light box such as the Carex Day-Light Classic, emitting 4000 Kelvin white light rated at 10,000 lux at 14 inches from screen to cornea, with an ultraviolet filter) for 30 minutes as soon as possible after awakening, preferably between 7:00-8:00 am. Participants will also taper and discontinue their antidepressant medication.

Based on this trial design, predict the completion outcome and termination type (if applicable).